Gail L Daumit, A Eden Evins, Corinne Cather, Arlene T Dalcin, Faith B Dickerson, Edgar R Miller, Lawrence J Appel, Gerald J Jerome, Una McCann, Daniel E Ford, Jeanne B Charleston, Deborah R Young, Joseph V Gennusa, Stacy Goldsholl, Courtney Cook, Tyler Fink, Nae-Yuh Wang
IMPORTANCE: Tobacco smoking drives markedly elevated cardiovascular disease risk and preventable death in persons with serious mental illness, and these risks are compounded by the high prevalence of overweight/obesity that smoking cessation can exacerbate. Guideline-concordant combined pharmacotherapy and behavioral smoking cessation treatment improves abstinence but is not routinely offered in community settings, particularly to those not seeking to quit smoking immediately. OBJECTIVE: To determine the effectiveness of an 18-month pharmacotherapy and behavioral smoking cessation intervention incorporating weight management and support for physical activity in adults with serious mental illness interested in quitting smoking within 1 or 6 months...
June 28, 2023: JAMA Psychiatry